IBEX Limited — Form 10-Q Summary
Reporting period: Fiscal third quarter and nine months ended March 31, 2024; comparable periods ended March 31, 2023. The filing is for FY2024 Q3, despite the request metadata referring to 2023 Q3. IBEX provides technology-enabled customer experience and business process outsourcing services and reports one operating segment.
Financial performance and position
| Metric | Three months ended March 31 | Nine months ended March 31 |
|---|---|---|
| Revenue | $126.8 million, down 3.6% year over year | $384.0 million, down 3.7% |
| Operating income / margin | $11.3 million / 8.9%, versus $13.1 million / 9.9% | $26.6 million / 6.9%, versus $32.2 million / 8.1% |
| Net income | $10.3 million, down 8.6% | $23.8 million, down 12.0% |
| Diluted EPS | $0.57, versus $0.59 | $1.29, versus $1.44 |
| Adjusted EBITDA / margin (non-GAAP) | $19.2 million / 15.1%, versus $18.8 million / 14.3% | $47.2 million / 12.3%, versus $51.1 million / 12.8% |
| Operating cash flow | $18.5 million for nine months, versus $24.4 million | |
| Free cash flow (non-GAAP) | $11.8 million for nine months, versus $9.2 million |
Cash and cash equivalents were $50.7 million at March 31, 2024, down from $57.4 million at June 30, 2023. Total debt was $1.4 million, consisting of finance leases; no revolving-credit borrowings were outstanding, and $80.0 million was available under the credit facility. Net cash was $49.3 million. Operating lease liabilities, which are separate from reported debt, totaled $68.7 million. Management said available cash, operating cash generation and credit availability should meet liquidity needs for at least 12 months.
Changes and drivers
- Revenue declines reflected macroeconomic softness and lower volumes in FinTech and Telecommunications, along with a shift in delivery from higher-priced onshore work to lower-priced offshore locations. Retail & E-commerce and Travel, Transportation & Logistics grew in the quarter; HealthTech, Retail & E-commerce and Travel, Transportation & Logistics grew over nine months.
- Cost of services fell faster than revenue, supported by lower payroll and site costs and a greater offshore delivery mix. SG&A rose 6.4% in the quarter and 10.0% over nine months, including impairment, severance and technology-related spending.
- GAAP operating margin and net income declined year over year. Quarterly adjusted EBITDA margin improved, which management attributed to cost optimization and offshore mix; the nine-month adjusted EBITDA margin declined.
- Operating cash flow decreased, while lower capital expenditures helped lift nine-month free cash flow. The $18.6 million of share repurchases was the primary driver of the decline in cash.
Outlook, risks and unusual items
- No specific revenue or earnings guidance is provided. Management said sales activity picked up in the third quarter, with 15 new clients won over nine months versus eight in the prior-year period, and expects offshore capacity to be absorbed as clients seek lower-cost delivery. It also expects macroeconomic pressures to continue near term.
- Management is developing its Wave iX generative-AI offering, focused on agent productivity, customer insights and voice/chat bots. AI adoption may create opportunities but also poses data-security, governance and implementation challenges.
- During the quarter, IBEX recorded $1.3 million of impairment losses on assets at two delivery locations and incurred about $1.5 million of severance costs over the nine-month period; $1.0 million remained accrued at March 31. It also capitalized $2.4 million of cloud software implementation costs over nine months.
- Foreign-exchange exposure is material: based on nine-month activity, a 10% currency move would change expenses by approximately $9.1 million for the Philippine peso, $4.3 million for the Jamaican dollar, and $2.8 million for the Pakistani rupee in the appreciation case; depreciation would reduce expenses by approximately $7.5 million, $3.5 million and $2.3 million, respectively. IBEX hedges a portion of Philippine-peso costs.
- A foreign jurisdiction issued an assessment in April 2024 relating to a fiscal 2020 audit. Management is contesting it and recorded no tax-benefit liability, determining the amount is contestable. The filing does not provide the assessment amount.
- Disclosure controls were not effective as of March 31, 2024 because of an unremediated material weakness concerning complex, non-routine transactions. Management said remediation is ongoing.
- The prior $30 million repurchase authorization expired March 18, 2024; IBEX repurchased $18.6 million of shares under it. On May 1, 2024, the board authorized a new program of up to $30 million over 12 months, intended to be funded from cash.
Key facts for investors to verify
- Whether revenue trends and new client wins offset continued softness in FinTech and Telecommunications, and how quickly offshore capacity is utilized.
- Whether reported profitability and cash generation improve after impairment, severance and planned technology, sales and service investments; compare GAAP results with non-GAAP measures and their reconciliations.
- The cash impact and terms of the new repurchase program, alongside operating lease obligations and the use of available credit.
- Developments in the contested tax assessment and whether foreign-exchange movements or labor-cost inflation affect margins.
- Progress and demonstrated effectiveness of the internal-control remediation plan; the material weakness remained unremediated at quarter-end.